The Scientist

» history, ecology and developmental biology

Most Recent

image: Fighting Cancer with Infection, 1891

Fighting Cancer with Infection, 1891

By | April 1, 2016

Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.

2 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.

1 Comment

image: Parallel Plagues

Parallel Plagues

By | April 1, 2016

Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.

0 Comments

image: Origins of Dysentery

Origins of Dysentery

By | March 22, 2016

Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.

0 Comments

Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.

0 Comments

image: Cave Dwellers, 1938

Cave Dwellers, 1938

By | March 1, 2016

Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.

2 Comments

image: Adjustable Brain Cells

Adjustable Brain Cells

By | February 18, 2016

Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.

1 Comment

image: Capsule Reviews

Capsule Reviews

By | February 1, 2016

Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.

1 Comment

image: Keep Off the Grass

Keep Off the Grass

By | February 1, 2016

Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.

0 Comments

image: Mendel in the Hot Seat, 1902

Mendel in the Hot Seat, 1902

By | February 1, 2016

Now hailed as the father of immunotherapy, William Coley pioneered extraordinary methods to treat cancer.

5 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech